Key Insights

Highlights

Treatment Research

1 treatments under study, led by Parentinfant Interxaction Intervention Pixi

Research Leaders

5 sponsors active, led by Netherlands Brain Foundation

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Enrolling By Invitation1

Clinical Trials (2)

Showing 2 of 2 trials
NCT03836300Not ApplicableEnrolling By Invitation

Parent and Infant Inter(X)Action Intervention (PIXI)

NCT00161109UnknownPrimary

Genetics and Psychopathology in the 22q11 Deletion Syndrome

Showing all 2 trials

Research Network

Common Treatments

  • Parentinfant Interxaction Intervention Pixi1

Active Sponsors

  • Netherlands Brain Foundation1
  • UMC Utrecht1
  • Children's Hospital of Philadelphia1
  • University of North Carolina, Chapel Hill1
  • RTI International1

Top Investigators

Related Conditions

  • Phelanmcdermid Syndrome1
  • Smith Magenis Syndrome1
  • Dup15q Syndrome1
  • Klinefelter Syndrome1
  • Down Syndrome1

Activity Timeline